The Exelon Patch is licensed for treating mild to moderate dementia due to Parkinson's and Alzheimer's disease. It can help improve cognitive function, but is not a cure for either condition. Exelon Patches, which are available by prescription, are generally applied to the skin once daily. Potential side effects can include nausea, diarrhea, and loss of appetite.
The Exelon® Patch (rivastigmine patch) is a prescription medication approved to treat mild to moderate dementia due to Alzheimer's disease or Parkinson's disease. Although the Exelon Patch is not a cure for these diseases, it can help with some of the symptoms. The patch provides the benefits of once-daily dosing and continuous release of the medication.
The Exelon Patch is made by Novartis Pharmaceuticals Corporation.
The Exelon Patch is part of a group of medications known as acetylcholinesterase inhibitors. These medications work by preventing a specific enzyme (known as acetylcholinesterase) from breaking down acetylcholine in the brain.
Acetylcholine is a chemical that aids in many brain functions, including memory, attention, reason, and language. Problems with inadequate acetylcholine in the brain may contribute to some of the symptoms of dementia associated with Alzheimer's disease or Parkinson's disease.
Exelon products (including the patches, as well as capsules and liquid) are the only acetylcholinesterase inhibitors approved to treat dementia due to Parkinson's disease. The other medications in this class are approved to treat Alzheimer's dementia only.